News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GrowBLOX Sciences, Inc. Names Chief Science Officer And Member Of The Board Of Directors



6/16/2014 8:05:06 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LAS VEGAS, June 16, 2014 /PRNewswire/ -- GrowBLOX Sciences, Inc. (OTCQB: GBLX) a biotechnology and research company, today announced that The Company has named its Chief Science Officer and Member of the Board of Directors, Dr. Andrea Small-Howard, PhD, MBA. Dr. Small-Howard comes to GrowBLOX Sciences with an extensive background in Biotechnology and Biopharmaceutical products.

Dr. Andrea Small-Howard leverages broad industry knowledge with a focus on managing new product development that can be commercialized in the U.S. and selected international markets. She employs an integrated approach to product commercialization, as her core product development perspective is augmented with manufacturing, regulatory, supply chain and corporate alliance experience. Dr. Small-Howard received her AB from Occidental College, in addition to receiving both an MBA and a PhD in Biological Sciences from the University of Southern California. As a post-doctoral fellow at the Queens Medical Center in Honolulu, Hawaii, she lead a project group dedicated to the study of cannabinoids in the immune system and published two peer-reviewed papers on the subject. She also screened synthetic cannabinoids at the in vitro and preclinical levels. Dr. Small-Howard has previously screened licensing candidates in other biotech disciplines and developed biopharma products that are currently on the market. She has also written and filed patents and global regulatory approvals.

GrowBLOX Sciences, CEO, Craig Ellins said, "I couldn't be happier to have Andrea on board. We have been building a business model based on our proprietary technology and with someone as talented and skilled in biotechnology as Andrea, we have the research and resources to help her build on the momentum of our product pipeline. Now that the FDA has fast tracked clinical trials for certain cannabinoid medicines, Andrea's experience in FDA product trials will position our team of scientists to a nutraceutical and pharmaceutical approved market."

About GrowBLOX Sciences, Inc.
GrowBLOX Sciences, Inc., is a research and biotechnical company that has developed proprietary indoor growing chambers specifically designed for medical cannabis cultivation. The GrowBLOX chamber allows for completely controlled growing conditions, ensuring the manufacture of a consistent, toxin-free, natural and medicinal-grade product. The Company believes that the advantages of a controlled environment over traditional outdoor or greenhouse growing, will empower the public, nutraceutical and pharmaceutical industries to embrace cannabis as an effective treatment for a myriad of serious medical conditions. http://www.gbsciences.com

Forward-Looking Statements
Except for historical information contained herein, the statements in this release are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are inherently unreliable and actual results may differ materially. Examples of forward-looking statements in this news release include statements regarding the payment of dividends, marketing and distribution plans, development activities and anticipated operating results. Factors which could cause actual results to differ materially from these forward-looking statements include such factors as the Company's ability to accomplish its business initiatives, significant fluctuations in marketing expenses and ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of its products and services, as well as the introduction of competing products, or management's ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and other information that may be detailed from time to time in the Company's filings with the United States Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:
Jonathan Barkman
Riverview Capital Enterprises
+1-866-845-0105

SOURCE GrowBLOX Sciences, Inc.



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES